Gene Solutions
PrivateLast Round
Series C
Nov 18, 2025
Total Funding Raised
$36M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gene Solutions is an international biotechnology company that provides a portfolio of genetic testing solutions, including non-invasive prenatal testing (NIPT) and early cancer detection, by integrating Next-Generation Sequencing (NGS) and Artificial Intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gene Solutions Comparables
Compare Gene Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lucence | 79% | |
| Nalagenetics | 77% | |
| Prenetics | 76% |
Gene Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 18, 2025 | ||||
| Series B Extension | Sep 20, 2023 | ||||
| Series B | Oct 5, 2021 |
Gene Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mekong Capital | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
$100M round completed.
- Sep 20, 2023
$21M round led by Mekong Capital.
Gene Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gene Solutions's valuation, stock price, and market status.
Is Gene Solutions a public or private company?
Gene Solutions is a private company.
What is the current stock price of Gene Solutions?
Gene Solutions is a private company with no public stock price. No recent secondary market data is available.
How much is Gene Solutions worth (valuation)?
Valuation information for Gene Solutions is not publicly available.
Can I buy Gene Solutions stock?
Gene Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gene Solutions's last funding round?
Gene Solutions's most recent funding round was Series C on November 18, 2025.
Who are the main investors in Gene Solutions?
Key investors in Gene Solutions include Mekong Capital.
Will Gene Solutions IPO soon?
No public IPO plans have been announced for Gene Solutions.
How can I track Gene Solutions secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gene Solutions's secondary market activity and sign up for updates.